Biojam distributes serological tests for COVID-19 validated by São João University Hospital


The Biojam Holding Group was the first Portuguese company to introduce the technique that allows for the evaluation of IgG and IgM antibodies for the new coronavirus. In statements to Just News, its founder and administrator, Carlos Jorge Monteiro, once again emphasizes the innovative trait of the group: "We had to reinvent ourselves. We were always seeking to bring differentiated products to the market."

Tested and validated by the Clinical Pathology Service of the São João University Hospital Center, these serological tests have already been acquired by multiple hospitals and private entities. They are characterized by "indicating whether we have already been infected or not, and whether we are immunized, in just 10 to 15 minutes," explains Carlos Jorge Monteiro.

Differing from PCR tests due to lower price and response time, it emphasizes, however, that "this test does not replace the swab test, but somehow adds the possibility of testing people who have been on the front line and may have been infected, although not showing any symptoms."

With this test made available for the first time in March and originating from the Netherlands, Biojam relies on a German manufacturer, which "upgraded the packaging, including lancets that were previously bought separately," explains Carlos Jorge Monteiro. He adds that the tests are being sold to Portugal, Spain, and Portuguese-speaking African Countries.

"It thus fills a gap in rapid diagnosis in the early stage of infection, which occurred with IgG and IgM serological antibody tests, since this test has a detection window similar to PCR tests,"

In addition to distributing these tests, which bear the CE mark according to European Union health and safety standards and are approved by Infarmed, Biojam also stands out for offering products from its dermocosmetics line, including hand creams, face creams, or hydration masks to help protect healthcare professionals.

"At some point, we thought we should play an interventionist role in the pandemic, and dermocosmetics could help healthcare professionals or all frontline forces. And that's what we've been doing since February until now," concludes the administrator of Biojam.

News published by